To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors
Clinical trial NCT01028755 · COMPLETED
Trial details
- NCT number
- NCT01028755
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2013-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.